NEOGEN
Neogen Chemicals
Each stock's 10,000-path forecast, rendered as light.
Neogen Chemicals (NEOGEN) Stock Analysis & Case Study
Is NEOGEN a good buy? The data-driven verdict.
Neogen Chemicals (NEOGEN) trades at ₹1,915,on the numbers it high-risk on the numbers, a Downstox Snapshot Score of 28/100.
On the numbers, Neogen Chemicals (NEOGEN) high-risk on the numbers, a Downstox Snapshot Score of 28/100, weighing expensive at 182.0× earnings, ROE of 3.6%, a 46% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027–2031.
Last updated . Data snapshot for research, not investment advice.
NEOGEN fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
Is NEOGEN overvalued? NEOGEN P/E vs its sector
NEOGEN's P/E of 182.0× sits above the sector peer median of 15.9×, so on earnings it screens richer than peers, while its 0.05% dividend yield is below the peer median of 1.65%.
NEOGEN share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 2.0y of NEOGEN history (7%/yr drift, 50%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| NEOGEN 2027 | ₹970 | ₹1,833 | ₹3,512 | -5% |
| NEOGEN 2028 | ₹699 | ₹1,748 | ₹4,356 | -9% |
| NEOGEN 2029 | ₹538 | ₹1,672 | ₹5,127 | -13% |
| NEOGEN 2030 | ₹436 | ₹1,593 | ₹5,680 | -18% |
| NEOGEN 2031 | ₹346 | ₹1,487 | ₹6,297 | -23% |
Median (P50) is the central estimate; the P10–P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability NEOGEN goes up, or doubles?
The bull case for NEOGEN
- Neogen Chemicals is part of the nifty500 universe with live, tracked fundamentals on Downstox.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹5,127.
The bear case & risks
- A rich 182.0× P/E leaves a thin margin of safety if growth slows.
- Return on equity is a soft 3.6%, capital efficiency trails higher-quality peers.
- High historical volatility (50%/yr) means a wide, bumpy range of outcomes, size positions accordingly.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹538.
NEOGEN volatility & expected range, how bumpy is the ride?
Over the last 2.0 years NEOGEN compounded at 7%/year with annualized volatility of 50%. That volatility implies a 1-year 80% range of ₹970–₹3,512, the honest backbone behind any single price target.
NEOGEN price forecast, the full 60-month probability fan
NEOGEN price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds NEOGEN hits common targets within the simulated horizon?
Full multi-horizon detail on the NEOGEN price target & forecast page.
NEOGEN Piotroski F-Score: 4/9, how financially strong is it?
The Piotroski F-Score grades financial strength on nine profitability, leverage and efficiency checks. NEOGEN scores 4/9,mixed financial health.
NEOGEN MTF margin & leverage, Upstox, Zerodha, Groww, Dhan
Margin Trading Facility lets you buy NEOGEN with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| UpstoxCHEAPEST | 37.8% | 2.6× |
| ZerodhaCHEAPEST | 37.8% | 2.6× |
| DhanCHEAPEST | 37.8% | 2.6× |
Compare every broker on the NEOGEN MTF page.
NEOGEN vs peers,sector comparison
About Neogen Chemicals: sector, index & market-cap context
Neogen Chemicals (NEOGEN) is a small-cap NSE-listed company, and a constituent of the Nifty 500 index group, with a market capitalisation of ₹5,247 Cr. See more Nifty 500 stocks.
How the NEOGEN Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Neogen Chemicals's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
NEOGEN analysis, FAQs
Is Neogen Chemicals (NEOGEN) a good buy?
On the numbers, Neogen Chemicals (NEOGEN) high-risk on the numbers, a Downstox Snapshot Score of 28/100, weighing expensive at 182.0× earnings, ROE of 3.6%, a 46% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is NEOGEN overvalued or undervalued?
NEOGEN trades at 182.0× earnings versus a peer median of 15.9×, so it screens richer than its sector peers.
What is the NEOGEN share price target for 2031?
NEOGEN's probability-weighted 2031 median target is ₹1,487, with an 80% range of ₹346–₹6,297 (10,000-path Monte-Carlo).
What is the probability NEOGEN doubles in 5 years?
The modelled probability of NEOGEN reaching ₹3,864 (2×) within 5 years is 20%.
What is the bull case for NEOGEN?
Neogen Chemicals is part of the nifty500 universe with live, tracked fundamentals on Downstox.
What are the risks in NEOGEN?
A rich 182.0× P/E leaves a thin margin of safety if growth slows. Return on equity is a soft 3.6%, capital efficiency trails higher-quality peers. High historical volatility (50%/yr) means a wide, bumpy range of outcomes, size positions accordingly.